Similar articles

• Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.

  Mahrle G, Schulze HJ, Färber L, Weidinger G, Steigleder GK. Mahrle G, et al. J Am Acad Dermatol. 1995 Jan;32(1):78-88. doi: 10.1016/0190-9622(95)90189-2. J Am Acad Dermatol. 1995. PMID: 7822521 Clinical Trial.
• Cyclosporine A in psoriasis.

  Rebora A. Rebora A. Clin Dermatol. 1991 Oct-Dec;9(4):515-22. doi: 10.1016/0738-081x(91)90081-u. Clin Dermatol. 1991. PMID: 1822409 Review. No abstract available.
• Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.

  Gottlieb SL, Heftler NS, Gilleaudeau P, Johnson R, Vallat VP, Wolfe J, Gottlieb AB, Krueger JG. Gottlieb SL, et al. J Am Acad Dermatol. 1995 Oct;33(4):637-45. doi: 10.1016/0190-9622(95)91286-x. J Am Acad Dermatol. 1995. PMID: 7545705
• Effect of cyclosporine on genital psoriasis and lichen planus.

  Jemec GB, Baadsgaard O. Jemec GB, et al. J Am Acad Dermatol. 1993 Dec;29(6):1048-9. doi: 10.1016/s0190-9622(08)82046-4. J Am Acad Dermatol. 1993. PMID: 8245246 Clinical Trial. No abstract available.
• Cyclosporine A in the treatment of psoriasis: a clinical and mechanistic perspective.

  Griffiths CE, Voorhees JJ. Griffiths CE, et al. J Invest Dermatol. 1990 Nov;95(5 Suppl):53S-55S. doi: 10.1111/1523-1747.ep12505786. J Invest Dermatol. 1990. PMID: 16788634 Review.